Immune-Onc Therapeutics
0 followers
Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in... Read more
Org chart
Charlene Liao
Founder, CEO & Chair
Charlene Liao
Collapse
Hong Xiang
Chief Development Officer
Maggie Gu
China General Manager
Roya Nawabi
Vice President, Head of Clinical Operations
Donna Valencia
Vice President, Head of Drug Safety
John Bergan
Vice President, Head of Regulatory Affairs
Penny Dong
Vice President, Project and Alliance Management
Wen Hong Lin
Vice President Clinical Development
Yasuhiro Tabata
Vice President Clinical Development
Xiao Min Schebye
Senior Director
Helen Y.
Medical Director
Kyu Hee Hong
Director of Bioanalysis
tao Huang
Director, Preclinical development
Sydney Ray
Senior Clinical Project Manager
